Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Clinical trial NCT00871494 · COMPLETED

Trial details

NCT number: NCT00871494
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pelvic Inflammatory Disease

Start date: 2009-05-01
Primary completion: 2010-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.